Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds
Shares:
For more than a quarter-century, I’ve been a member of the National Association of Science Writers, a group that does great work supporting a broad range of folks who write
Inflection Point The thorniest problem in biopharmaceuticals is the growing conflict between cost-effectiveness and budget impact. In other words, we increasingly have weapons against disease that are, objectively and
It’s not often that I get excited about more email, but lawyer Bill Sarraille has a new newsletter that is worth the click. I link to Bill’s work on LinkedIn